Conference Poster
Year : 2018
Geneviève Michel : Connect in order to contact the contributor
https://hal.univ-brest.fr/hal-01950797
Submitted on : Tuesday, December 11, 2018-9:26:15 AM
Last modification on : Wednesday, October 30, 2024-6:08:04 PM
Dates and versions
Identifiers
- HAL Id : hal-01950797 , version 1
Cite
P. Hilliquin, T Barnetche, G Baudens, R. Niarra, I Idier, et al.. Subcutaneous Tocilizumab in Monotherapy or in Combination with DMARD in Patients with Moderate to Severe Active Rheumatoid Arthritis: Observational Study to Describe Real-World Drug Retention Rate at 12 Months, Interim Analysis. ACR/ARHP Annual Meeting, Oct 2018, Chicago, France. 70 (suppl 10) (Abstract 573), Arthritis Rheumatology. ⟨hal-01950797⟩
Collections
33
View
0
Download